Vascular endothelial growth factor: a neurovascular target in neurological diseases
C Lange, E Storkebaum, CR De Almodóvar… - Nature Reviews …, 2016 - nature.com
Brain function critically relies on blood vessels to supply oxygen and nutrients, to establish a
barrier for neurotoxic substances, and to clear waste products. The archetypal vascular …
barrier for neurotoxic substances, and to clear waste products. The archetypal vascular …
Current and possible future therapeutic options for Huntington's disease
MW Ferguson, CJ Kennedy… - Journal of central …, 2022 - journals.sagepub.com
Huntington's disease (HD) is an autosomal neurodegenerative disease that is characterized
by an excessive number of CAG trinucleotide repeats within the huntingtin gene (HTT). HD …
by an excessive number of CAG trinucleotide repeats within the huntingtin gene (HTT). HD …
Protective role of IGF-1 and GLP-1 signaling activation in neurological dysfunctions
Abstract Insulin-like growth factor-1 (IGF-1), a pleiotropic polypeptide, plays an essential role
in CNS development and maturation. Glucagon-like peptide-1 (GLP-1) is an endogenous …
in CNS development and maturation. Glucagon-like peptide-1 (GLP-1) is an endogenous …
Patterns of CAG repeat instability in the central nervous system and periphery in Huntington's disease and in spinocerebellar ataxia type 1
R Mouro Pinto, L Arning, JV Giordano… - Human molecular …, 2020 - academic.oup.com
The expanded HTT CAG repeat causing Huntington's disease (HD) exhibits somatic
expansion proposed to drive the rate of disease onset by eliciting a pathological process …
expansion proposed to drive the rate of disease onset by eliciting a pathological process …
Small molecule splicing modifiers with systemic HTT-lowering activity
A Bhattacharyya, CR Trotta, J Narasimhan… - Nature …, 2021 - nature.com
Huntington's disease (HD) is a hereditary neurodegenerative disorder caused by expansion
of cytosine-adenine-guanine (CAG) trinucleotide repeats in the huntingtin (HTT) gene …
of cytosine-adenine-guanine (CAG) trinucleotide repeats in the huntingtin (HTT) gene …
AAV5-miHTT gene therapy demonstrates broad distribution and strong human mutant huntingtin lowering in a Huntington's disease minipig model
MM Evers, J Miniarikova, S Juhas, A Vallès… - Molecular Therapy, 2018 - cell.com
Huntington's disease (HD) is a fatal neurodegenerative disorder caused by a CAG
trinucleotide repeat expansion in the huntingtin gene. Previously, we showed strong …
trinucleotide repeat expansion in the huntingtin gene. Previously, we showed strong …
Hypothalamic alterations in neurodegenerative diseases and their relation to abnormal energy metabolism
P Vercruysse, D Vieau, D Blum, Å Petersén… - Frontiers in molecular …, 2018 - frontiersin.org
Neurodegenerative diseases (NDDs) are disorders characterized by progressive
deterioration of brain structure and function. Selective neuronal populations are affected …
deterioration of brain structure and function. Selective neuronal populations are affected …
Current pharmacological approaches to reduce chorea in Huntington's disease
EM Coppen, RAC Roos - Drugs, 2017 - Springer
There are currently no effective pharmacological agents available to stop or prevent the
progression of Huntington's disease (HD), a rare hereditary neurodegenerative disorder. In …
progression of Huntington's disease (HD), a rare hereditary neurodegenerative disorder. In …
Hypoxia-inducible factor (HIF) in ischemic stroke and neurodegenerative disease
EV Mitroshina, MO Savyuk, E Ponimaskin… - Frontiers in cell and …, 2021 - frontiersin.org
Hypoxia is one of the most common pathological conditions, which can be induced by
multiple events, including ischemic injury, trauma, inflammation, tumors, etc. The body's …
multiple events, including ischemic injury, trauma, inflammation, tumors, etc. The body's …
5΄-Vinylphosphonate improves tissue accumulation and efficacy of conjugated siRNAs in vivo
Abstract 5΄-Vinylphosphonate modification of siRNAs protects them from phosphatases, and
improves silencing activity. Here, we show that 5΄-vinylphosphonate confers novel …
improves silencing activity. Here, we show that 5΄-vinylphosphonate confers novel …